Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “AIDS (Acquired Immunodeficiency Syndrome)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01026727
What this trial is testing

Assess the Long-term Efficacy (24 Weeks) of MPC-4326 in Combination With a 2-3 Drug OBR Relative to the Efficacy of a 3-4 Drug ARV Regimen in Treatment Experienced HIV-1 Infected Subjects Who Are Failing Current Antiretroviral Therapy

Who this might be right for
HIV Infections
Myrexis Inc. 2
Not applicableEnrolling By InvitationNCT07053527
What this trial is testing

Welcome to PrEP School Utilizing Peer Educators to Improve Uptake of Preexposure Prophylaxis for HIV at an HBCU

Who this might be right for
HIV Prevention Program
Morehouse School of Medicine 123
Very early researchStudy completedNCT03197961
What this trial is testing

Pharmacokinetics and Pharmacodynamics of DMPA With HIV PrEP

Who this might be right for
HIV/AIDSContraception
Sharon Achilles 15
Not applicableStudy completedNCT02338024
What this trial is testing

Enhancing Linkage to HIV Care for Newly Detected HIV-positive Persons in Ukraine

Who this might be right for
HIV
Ukrainian Institute on Public Health Policy 276
Early research (Phase 1)Study completedNCT03575962
What this trial is testing

Compare the Relative Bioavailability of Two Different Formulations of GSK3640254

Who this might be right for
HIV Infections
ViiV Healthcare 14
Large-scale testing (Phase 3)WithdrawnNCT00476983
What this trial is testing

Pharmacokinetic and Efficacy of SQV/r 1500/100 Plus Tenofovir/Emtricitabine 300/200 mg

Who this might be right for
Saquinavir/Ritonavir BID or Lopinavir/Ritonavir BID
The HIV Netherlands Australia Thailand Research Collaboration
Testing effectiveness (Phase 2)Ended earlyNCT00432419
What this trial is testing

Therapeutic Intensification of HIV-associated Non-Hodgkin's Lymphoma by Peripheral Blood Cell Transplantation Following Chemotherapy.

Who this might be right for
HIV InfectionsLymphoma, Non-Hodgkin
French National Agency for Research on AIDS and Viral Hepatitis 1
Large-scale testing (Phase 3)WithdrawnNCT00011128
What this trial is testing

Salvage Treatment, Resistance Testing, and Withdrawal of Anti-HIV Drugs for HIV Patients Failing Current Anti-HIV Treatment

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Testing effectiveness (Phase 2)Study completedNCT00000912
What this trial is testing

A Study on Amprenavir in Combination With Other Anti-HIV Drugs in HIV-Positive Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 475
Not applicableStudy completedNCT03411265
What this trial is testing

RETAIN: Retaining Opioid Users Entering Medication Assisted Treatment and Encouraging HCV/HIV Testing

Who this might be right for
Opioid-Related DisordersOpioid-use DisorderDrug Addiction+1 more
University of Cincinnati 40
Testing effectiveness (Phase 2)Study completedNCT01146119
What this trial is testing

Further Investigation of an Intramuscular Influenza Vaccine (Multimeric-001)

Who this might be right for
Influenza
BiondVax Pharmaceuticals ltd. 200
Not applicableStudy completedNCT03848728
What this trial is testing

Strategic Antiretroviral Therapy and HIV Testing for Youth in Rural Africa

Who this might be right for
HIV
University of California, San Francisco 1,988
Large-scale testing (Phase 3)Study completedNCT02178592
What this trial is testing

Open-label Study of Dolutegravir (DTG) or Efavirenz (EFV) for Human Immunodeficiency Virus (HIV) - Tuberculosis (TB) Co-infection

Who this might be right for
Infection, Human Immunodeficiency VirusHIV Infections
ViiV Healthcare 113
Early research (Phase 1)Study completedNCT05245292
What this trial is testing

3BNC117-LS and 10-1074-LS Plus N-803 (bNAb+N-803)

Who this might be right for
Human Immunodeficiency Virus
Rockefeller University 28
Testing effectiveness (Phase 2)Study completedNCT00002395
What this trial is testing

Safety and Effectiveness of Topotecan HCl to Treat HIV-Infected Patients With AIDS-Related Progressive Multifocal Leukoencephalopathy (PML)

Who this might be right for
HIV InfectionsLeukoencephalopathy, Progressive Multifocal
SmithKline Beecham 54
Not applicableStudy completedNCT04013295
What this trial is testing

Prize-linked Savings Initiatives for Promoting Better Health and Economic Outcomes in Kenya

Who this might be right for
HIV/AIDS
University of Pennsylvania 300
Not applicableWithdrawnNCT00770419
What this trial is testing

Perceptions of Burden in Patients With Late-Stage Cancer and Their Caregivers

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersDepression+7 more
Rutgers, The State University of New Jersey
Post-approval studies (Phase 4)Temporarily pausedNCT00143728
What this trial is testing

3TC or No 3TC for HIV With 3TC Resistance

Who this might be right for
HIV Infections
University of British Columbia 152
Not applicableLooking for participantsNCT06541028
What this trial is testing

Reducing Stigma in People Who Inject Drugs (PWID) With HIV Using a Rapid Start Antiretroviral Therapy Intervention (ART)

Who this might be right for
HivDrug Use
Yale University 135
Testing effectiveness (Phase 2)Study completedNCT00001081
What this trial is testing

Nitazoxanide in Patients With AIDS and Diarrhea Caused by Cryptosporidium

Who this might be right for
CryptosporidiosisHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 60
Next Page